Central team approves location for Metropolitan Surveillance Unit in Pune
After three years of hiccups, the central team of experts has finally approved the location to set up the metropolitan surveillance unit (MSU) in Kasba Peth, Pune. The MSU is a special unit with a laboratory facility aimed at understanding the nature and cause of diseases in an urban context and identifying potential disease outbreaks, officials said.
According to officials, the MSU project in Pune is part of the central government's pilot project under the Integrated Disease Surveillance Programme (IDSP) with the latter funding it. The Pune Municipal Corporation (PMC) since 2021 has been unable to provide a dedicated space that meets the required technical specifications of the unit. So much so that the central authorities were considering scrapping the decision to set up an MSU at one point. However, during a visit on May 9, a 5,000 square feet space in Jawale Bhavan, Kasba Peth, was approved for setting up the MSU, officials said.
A senior official from the PMC on request of anonymity revealed that previously, two locations in Baner had been identified but both were rejected as they failed to meet the required technical specifications of the MSU. 'This time, the location was identified only after consultation with and recommendation of the civic building and electrical department due to which it has been approved as prior requirements have been fulfilled. Besides, the central team has agreed to release funds for the unit,' the official said.
For the past three years, the PMC health department has been struggling to provide the ideal location for the MSU and has been sending proposal requests to the central government for fund allocation. Now, both the location and budget proposal of ₹8.28 crore has been approved. The Pimpri-Chinchwad Municipal Corporation (PCMC) commissioner has given approval to the project in December 2024. As per officials, the MSU will identify alerts to be issued for infectious disease outbreaks and provide technical guidance for effective response. Once operational, the MSU will facilitate disease surveillance and prompt action against various disease outbreaks and epidemics.
Furthermore, the PMC has released a public notification in March to hire 24 expert staff for the unit. The scrutiny of applications is underway. The PMC will bear the cost of salaries of the appointed staff. The staff will be appointed within a month and will be trained by the central government, officials said.
PMC to constitute committee to set up lab
The MSU will also have an in-house laboratory of Bio-Safety Level 2 (BSL-2) to test samples for various infectious diseases. The central team has directed the PMC to constitute a technical team of experts that will give technical recommendations to set up the lab.
The technical committee will have experts from the National Institute of Virology, Pune; Sassoon General Hospital; public health department; and microbiology department of the PMC-run medical college among others. The committee will be appointed soon, PMC officials said.
Dr Nina Borade, health chief of the PMC, said that following their request, the central team visited Pune in just three days and the location for the MSU was finalised. 'They have also agreed to release funds for the project and the PCMC too will initially provide around ₹50 lakh for the unit. We have written to the electrical and building department to carry out refurbishment and electrical work at the location,' she said.
Dr Borade further said that during the Guillain Barre Syndrome (GBS) outbreak, officials had to struggle to conduct management and containment activities. Apart from these, the analysis and reporting had to be done. 'The MSU is helpful during such a situation and will be a great help in future during similar disease outbreaks,' she said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
10 hours ago
- The Hindu
Spike in leptospirosis cases worries Health department in Kerala
Leptospirosis is yet again emerging as the single most disease killing the maximum number of people every year in Kerala. While the pattern has been the same for the past several years, what has been immensely worrying the Health department is the huge jump in leptospirosis cases and mortality in the last three years. Despite the early public health alerts and doxycycline prophylaxis strategy initiated by the department or the PCR testing facilities launched for early confirmation of the disease, leptospirosis continues to be a significant cause of mortality. The disease, which used to spike during the rainy season, is no longer a seasonal one and more cases and deaths are reported even in the dry season too. Since 2022 when the Integrated Disease Surveillance programme began entering the 'probable' cases and deaths due to infectious diseases such as dengue and leptospirosis in the official records that the mortality due to leptospirosis began standing out. In 2022, the State recorded 5,315 probable and confirmed cases of leptospirosis and 290 deaths (both probable and confirmed). The very next year, 5,186 cases and 282 deaths were recorded. In 2024, the number of cases jumped to 5,980 and the deaths to 394. This year too, the picture looks quite alarming, with 1,451 cases and 74 deaths recorded till June 9. Complications Late diagnosis as well as complications and organ damage due to co-infections of dengue-leptospirosis are often cited as the major reasons for the serious loss of lives. However, the lack of intensive care facilities at the secondary level hospitals in districts is pointed out to be another important factor that could be contributing to the high mortality due to leptospirosis. Early diagnosis of leptospirosis, a disease which presents as a high febrile illness, myalgia and headache, may not be easy as it is difficult to distinguish it from dengue or other tropical diseases, just by clinical symptoms alone. However, laboratory diagnosis of leptospirosis is also quite challenging. Current serological tests for antibodies, like ELISA, take at least seven days to give results and this totally eludes diagnosis in the acute phase of the disease. In recent years, the Health department has introduced PCR tests for identifying leptospirosis early. However, these molecular tests are not widely available. Leptospirosis ranges from subclinical or mild illness (anicteric) in 90%-95% cases and it is a small proportion of the cases — about 5%-10% — which can develop into a serious illness, the prognosis of which might be unpredictable. People sometimes present late at the hospital after self-treatment for days together and the deterioration into multi-organ failure and pulmonary involvement can be rapid. These patients who develop serious illness require intensive management, but often this is where the public health system falters. A senior doctor in the Health Service points out that the intensive care units in secondary care level hospitals cannot be run 24 x7 because of acute shortage of nursing staff. Patients thus get referred to medical college hospitals, overcrowding the system. Impossible to eliminate Public health experts point out that leptospirosis is a risk which cannot be eliminated because over 280 serovars of the bacteria are spread out in the environment, the soil around us and these environmental factors are something over which no human controls are possible. Many clinicians maintain that focus has to be back on preventing leptospirosis because there are limits to how early the disease can be diagnosed and how well it can be managed. The Health department has been relying on doxycycline prophylaxis to counter the threat of leptospirosis for years now. Doctors point out that doxycycline has been found to be highly efficient even when one has been exposed to the infectious agent, provided it is consumed as per the guidelines. Yet people tend to ignore the health advisories or do not consume them as per guidelines, officials say. As leptospirosis predominantly seems to affect those in the low-socioeconomic groups and essentially those whose occupation puts them in constant contact with soil and water — dairy farmers, farmers, animal handlers, manual labourers, gardeners — the message that doxycycline prophylaxis can be life-saving should be consistently and repeatedly communicated amongst these high-risk groups.
News18
11 hours ago
- News18
XFG: What Is The New Covid Variant Detected In India Amid Rising Cases? Explained
Last Updated: Amid this surge, the new variant of the SARS-CoV-2 was detected with as many as 163 cases reported so far, of which the most are from Maharashtra at 89 India recorded a total of 6,815 active coronavirus cases with three deaths in the last 24 hours. Amid this surge, XFG – a new variant of the SARS-CoV-2 – was detected with as many as 163 cases reported so far. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the XFG variant has been found in a total of 163 samples – highest (89) in Maharashtra, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh and West Bengal (six each). A RECOMBINANT VARIANT: WHAT DOES THIS MEAN? An article in Lancet stated that the recombinant XFG variant harbours four key spike mutations and has achieved rapid global spread following its initial detection in Canada. Data shows that in May, as many as 159 samples were detected with the XFG variant while two samples were tested for this variant in April and two in June. It is essentially the result of two earlier strains — LF.7 and LP.8.1.2 — merging together. A recombinant variant like XFG emerges when someone is infected with two different versions of the virus at the same time, allowing it to 'mix and match" its genetic code. The Lancet study points out that this variant shows 'strong immune evasion". WHAT IS THE CENTRE DOING? According to the Union health ministry data released on June 8, Kerala continues to be the most affected state, followed by Gujarat, West Bengal and Delhi. Official sources have said due to the rising cases, the Centre is conducting mock drills to check facility-level preparedness and has instructed all states to ensure availability of oxygen, isolation beds, ventilators, and essential medicines. They maintained that most cases are mild and managed under home care. Since January this year, 65 deaths have been reported in the country. There were a total of 257 active patients in the country on May 22. A series of technical review meetings were held on June 2 and 3 under the chairpersonship of Dr Sunita Sharma, Director General of Health Services, to evaluate the Covid situation and preparedness measures. Representatives from the Disaster Management Cell, Emergency Management Response Cell, National Centre for Disease Control, Indian Council of Medical Research, Integrated Disease Surveillance Programme, central government hospitals in Delhi, and all states and Union Territories were part of the meeting. State and district surveillance units under the Integrated Disease Surveillance Programme are closely monitoring Influenza-Like Illness (ILI) and Severe Acute Respiratory Illness (SARI). 'Testing is recommended for all admitted SARI cases and 5 per cent of ILI cases as per guidelines, and positive SARI samples are sent for Whole Genome Sequencing through the ICMR VRDL network, " an official source said. First Published: June 10, 2025, 19:34 IST
Hindustan Times
a day ago
- Hindustan Times
Covid situation in control, no need to panic: PMC
Despite a noticeable uptick in the number of Covid-19 cases recently, Pune Municipal Corporation (PMC) officials claim that the situation in the city is under control and there is no need to panic. Civic officials said that existing Covid management protocols will continue to be followed. On Monday, the PMC held a review meeting to assess the Covid-19 situation in the city. The meeting was chaired by additional municipal commissioner M J Pradeep Chandran, and attended by representatives from the PMC health department, public health officials, and the Rapid Response Task Force. Experts from key institutions such as the National Chemical Laboratory (NCL), National Institute of Virology (NIV), B J Medical College (BJMC), and private hospitals also attended the meeting, according to officials. The RRT members said that the current virus strain in circulation is mild and no deaths have been reported in the city. The PMC till date has sent 145 Covid samples for genome sequencing and no new variant has been found. Besides, patients hospitalised with influenza-like illness (ILI) and severe acute respiratory infection (SARI) will be tested for Covid. Dr Nina Borade, health chief of the PMC, said, 'The Covid situation in the city is under control and the situation is not alarming. However, experts have stressed that individuals in high-risk categories, with existing co-morbid conditions should take precautions. We have asked all private hospitals to test SARI and ILI patients for Covid.' As per the statement issued by the public health department, Maharashtra on Monday reported 65 fresh Covid cases with 26 from areas under the PMC, 22 from Mumbai, and two from areas under the Pimpri-Chinchwad Municipal Corporation (PCMC). Since January, 1,504 Covid cases and 18 deaths amongst the infected have been reported. Furthermore, there are 613 active Covid-19 cases in the state. Since January, Mumbai has reported 687 cases, 681 of which were reported in May alone, said Dr Babita Kamlapurkar, joint director of health services. Dr Kamlapurkar said that instructions have been issued to all officers in the divisional, district, and municipal corporations across the state during the Covid-19 review meeting. 'Surveillance for ILI and SARI patients is being conducted regularly, with 5% of these patients being asked to undergo testing for Covid-19. All Covid-positive samples are sent for whole genome sequencing. Additionally, all healthcare facilities under the public health department, medical colleges within the medical education department, and hospitals and medical colleges in urban areas are directed to be prepared for Covid-19 testing and treatment,' she said.
